Merck & Sanofi Pasteur: Complex Partnerships – Collaborating effectively in the development of a hexavalent combination vaccine

In Partnering and Corporate strategy, Prophylactic Vaccines, R&D by Maria RelakiLeave a Comment

Christian Steber - sanofi pasteurAnne Aunis - Merck

One of my personal favourite presentations at this year's 12th annual World Vaccine Congress Washington, was the unique and very interesting co-presented talk from 2 of the biggest players in the vaccine industry, Merck & Sanofi Pasteur.

It proves that partnering is the way forward in this industry as well, and what better example to follow than theirs.

Both presenters, Anne Aunins (Merck) and Christian Steber (Sanofi Pasteur) talked us through their internal processes and the very successful communication plan they follow to keep everything on track and continue to focus their efforts into what matters.

During their talk they touched upon the fundamentals of this collaboration and talked us through:

  • The importance of combination vaccines in simplifying paediatric immunization and improving coverage
  • Lessons learned and next steps

For more information, download their presentation here.

Anne Aunins is a Senior Project Leader at Merck Research Laboratories (MRL) and Merck’s lead for this investigational pediatric hexavalent vaccine Anne has worked in drug and vaccine development throughout her 20-year career, holding a wide range of process development, technology transfer, regulatory, and project leadership roles in both research and manufacturing.

Christian Steber is the Director, R&D Projects at Sanofi Pasteur and he is responsible for leading the development of new vaccine projects. He has 20 years of experience in the pharmaceutical/vaccine industry starting in Quality and with the last 10 years focused on managing new vaccine projects.

Sanofi Pasteur was also nominated and won the award for "Best Pharma Vaccine Pipeline" at the 5th annual ViE Awards.

Leave a Comment

Current ye@r *